|
Sunrest Lifescience Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
18.45 Cr.
|
P/BV
|
1.13
|
Book Value (Rs.)
|
38.01
|
|
52 Week High/Low (Rs.)
|
75/39
|
FV/ML
|
10/1600
|
P/E(X)
|
9.20
|
|
Bookclosure
|
28/09/2024
|
EPS (Rs.)
|
4.67
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR |
| FaceValue | 10.00 |
| | |
| | |
| INCOME | |
| Revenue From Operations [Net] | 33.41 |
| Total Operating Revenues | 33.41 |
| Total Revenue | 33.42 |
| | |
| EXPENSES | |
| Cost Of Materials Consumed | 0.24 |
| Purchase Of Stock-In Trade | 21.58 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -1.73 |
| Employee Benefit Expenses | 4.86 |
| Finance Costs | 0.31 |
| Depreciation And Amortisation Expenses | 0.10 |
| Other Expenses | 5.45 |
| Total Expenses | 30.79 |
| | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 2.62 |
| | |
| Profit/Loss Before Tax | 2.62 |
| | |
| Tax Expenses-Continued Operations | |
| Current Tax | 0.61 |
| Total Tax Expenses | 0.61 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 2.01 |
| | |
| Profit/Loss From Continuing Operations | 2.01 |
| | |
| Profit/Loss For The Period | 2.01 |
| | |
| Minority Interest | -0.01 |
| Consolidated Profit/Loss After MI And Associates | 2.01 |
| | |
| OTHER INFORMATION | |
| | |
| EARNINGS PER SHARE | |
| Basic EPS (Rs.) | 4.67 |
| Diluted EPS (Rs.) | 4.67 |
